Global and Region Geriatric Medicine Market Demand & Opportunity Outlook 2022-2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Geriatrics, or geriatric medicine, is a specialty that focuses on health care of elderly people. It aims to promote health by preventing and treating diseases and disabilities in older adults.

    The elderly population basically exhibits conditions such as high cholesterol levels, low immune levels and high blood sugar levels, which greatly promotes the prevalence of target diseases such as hypertension, coronary heart disease, stroke, diabetes, and neurological diseases.

    One of the key factors contributing to the rapid growth of the geriatric medicine market is the rapid increase in the elderly population. The global prevalence of various target diseases has risen, immunity has fallen, and the significant improvement of the healthcare system has greatly promoted the growth of the market.

    The report details the trend, potential and market size of Geriatric Medicine market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Geriatric Medicinemarket, defines the market attractiveness level of Geriatric Medicine market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Geriatric Medicine industry, describes the types of Geriatric Medicine market, the applications of major players and the market size, and deeply analyzes the current situation of the global Geriatric Medicine market and the development prospects and opportunities of Geriatric Medicine industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Geriatric Medicine market in Chapter 13.

    By Player:

    • Merck

    • Boehringer Ingelheim

    • Bristol-Myers Squibb

    • Abbott

    • Eli Lilly

    • Pfizer

    • Novartis

    • AstraZeneca

    • GSK

    By Type:

    • Analgesics

    • Antihypertensives

    • Antidiabetics

    • Antipsychotic

    • Antidepressant

    • Other

    By End-User:

    • Hospitals

    • Clinics

    • Other

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Geriatric Medicine Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Geriatric Medicine Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Geriatric Medicine Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Geriatric Medicine Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Geriatric Medicine Market Analysis and Outlook to 2022

    • 7.1 Global Geriatric Medicine Consumption (2017-2022)

    • 7.2 United States Geriatric Medicine Consumption (2017-2022)

    • 7.3 Europe Geriatric Medicine Consumption (2017-2022)

    • 7.4 China Geriatric Medicine Consumption (2017-2022)

    • 7.5 Japan Geriatric Medicine Consumption (2017-2022)

    • 7.6 India Geriatric Medicine Consumption (2017-2022)

    • 7.7 South Korea Geriatric Medicine Consumption (2017-2022)

    8 Region and Country-wise Geriatric Medicine Market Analysis and Outlook to 2028

    • 8.1 Global Geriatric Medicine Consumption Forecast (2022-2028)

    • 8.2 United States Geriatric Medicine Consumption Forecast (2022-2028)

    • 8.3 Europe Geriatric Medicine Consumption Forecast (2022-2028)

    • 8.4 China Geriatric Medicine Consumption Forecast (2022-2028)

    • 8.5 Japan Geriatric Medicine Consumption Forecast (2022-2028)

    • 8.6 India Geriatric Medicine Consumption Forecast (2022-2028)

    • 8.7 South Korea Geriatric Medicine Consumption Forecast (2022-2028)

    9 Global Geriatric Medicine Market Outlook by Types and Applications to 2022

    • 9.1 Global Geriatric Medicine Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Analgesics Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Antihypertensives Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Antidiabetics Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Antipsychotic Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Antidepressant Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Other Consumption and Growth Rate (2017-2022)

    • 9.2 Global Geriatric Medicine Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Other Consumption and Growth Rate (2017-2022)

    10 Global Geriatric Medicine Market Outlook by Types and Applications to 2028

    • 10.1 Global Geriatric Medicine Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Analgesics Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Antihypertensives Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Antidiabetics Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Antipsychotic Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Antidepressant Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.6 Global Other Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Geriatric Medicine Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)

    11 Global Geriatric Medicine Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Geriatric Medicine Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Geriatric Medicine Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Geriatric Medicine Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Geriatric Medicine Market Competitive Analysis

    • 14.1 Merck

      • 14.1.1 Merck Company Details

      • 14.1.2 Merck Geriatric Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Merck Geriatric Medicine Product and Service

    • 14.2 Boehringer Ingelheim

      • 14.2.1 Boehringer Ingelheim Company Details

      • 14.2.2 Boehringer Ingelheim Geriatric Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Boehringer Ingelheim Geriatric Medicine Product and Service

    • 14.3 Bristol-Myers Squibb

      • 14.3.1 Bristol-Myers Squibb Company Details

      • 14.3.2 Bristol-Myers Squibb Geriatric Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Bristol-Myers Squibb Geriatric Medicine Product and Service

    • 14.4 Abbott

      • 14.4.1 Abbott Company Details

      • 14.4.2 Abbott Geriatric Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Abbott Geriatric Medicine Product and Service

    • 14.5 Eli Lilly

      • 14.5.1 Eli Lilly Company Details

      • 14.5.2 Eli Lilly Geriatric Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Eli Lilly Geriatric Medicine Product and Service

    • 14.6 Pfizer

      • 14.6.1 Pfizer Company Details

      • 14.6.2 Pfizer Geriatric Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Pfizer Geriatric Medicine Product and Service

    • 14.7 Novartis

      • 14.7.1 Novartis Company Details

      • 14.7.2 Novartis Geriatric Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Novartis Geriatric Medicine Product and Service

    • 14.8 AstraZeneca

      • 14.8.1 AstraZeneca Company Details

      • 14.8.2 AstraZeneca Geriatric Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 AstraZeneca Geriatric Medicine Product and Service

    • 14.9 GSK

      • 14.9.1 GSK Company Details

      • 14.9.2 GSK Geriatric Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 GSK Geriatric Medicine Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Geriatric Medicine

    • Figure Geriatric Medicine Picture

    • Table Global Geriatric Medicine Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Geriatric Medicine Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Geriatric Medicine Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Geriatric Medicine Consumption by Country (2017-2022)

    • Figure United States Geriatric Medicine Consumption and Growth Rate (2017-2022)

    • Table Europe Geriatric Medicine Consumption and Growth Rate (2017-2022)

    • Figure China Geriatric Medicine Consumption and Growth Rate (2017-2022)

    • Figure Japan Geriatric Medicine Consumption and Growth Rate (2017-2022)

    • Figure India Geriatric Medicine Consumption and Growth Rate (2017-2022)

    • Figure South Korea Geriatric Medicine Consumption and Growth Rate (2017-2022)

    • Figure Global Geriatric Medicine Consumption Forecast by Country (2022-2028)

    • Figure United States Geriatric Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Geriatric Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Geriatric Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Geriatric Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Geriatric Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Geriatric Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Analgesics Consumption and Growth Rate (2017-2022)

    • Figure Global Antihypertensives Consumption and Growth Rate (2017-2022)

    • Figure Global Antidiabetics Consumption and Growth Rate (2017-2022)

    • Figure Global Antipsychotic Consumption and Growth Rate (2017-2022)

    • Figure Global Antidepressant Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Analgesics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Antihypertensives Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Antidiabetics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Antipsychotic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Antidepressant Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Geriatric Medicine Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Geriatric Medicine Export by Region (Top 5 Countries) (2017-2028)

    • Table Merck (Foundation Year, Company Profile and etc.)

    • Table Merck Geriatric Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Geriatric Medicine Product and Service

    • Table Boehringer Ingelheim (Foundation Year, Company Profile and etc.)

    • Table Boehringer Ingelheim Geriatric Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Boehringer Ingelheim Geriatric Medicine Product and Service

    • Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)

    • Table Bristol-Myers Squibb Geriatric Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol-Myers Squibb Geriatric Medicine Product and Service

    • Table Abbott (Foundation Year, Company Profile and etc.)

    • Table Abbott Geriatric Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott Geriatric Medicine Product and Service

    • Table Eli Lilly (Foundation Year, Company Profile and etc.)

    • Table Eli Lilly Geriatric Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly Geriatric Medicine Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Geriatric Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Geriatric Medicine Product and Service

    • Table Novartis (Foundation Year, Company Profile and etc.)

    • Table Novartis Geriatric Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Geriatric Medicine Product and Service

    • Table AstraZeneca (Foundation Year, Company Profile and etc.)

    • Table AstraZeneca Geriatric Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca Geriatric Medicine Product and Service

    • Table GSK (Foundation Year, Company Profile and etc.)

    • Table GSK Geriatric Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table GSK Geriatric Medicine Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.